Evidence map›Paper›PMID 33877432›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

Oral tongue squamous cell carcinomas in young patients according to their smoking status: a GETTEC study.

Sophie Deneuve, Joanne Guerlain, Agnès Dupret-Bories, Claire Majoufre, Pierre Philouze, Philippe Ceruse, Marion Perreard, Nicolas Sigaud, Béatrix Barry, Pierre Ransy and 9 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 2 countries.

Sophie DeneuveSurgical Oncology Department, Léon Bérard Comprehensive Cancer Center, 28 rue Laennec, 69008, Lyon, France. fdeneuve@club.fr.ORCID http://orcid.org/0000-0001-7044-7869
Joanne GuerlainHead and Neck Department, Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
Agnès Dupret-BoriesHead and Neck Department, Toulouse University Cancer Institute, Toulouse, France.
Claire MajoufreMaxillofacial Surgery, CHU Bordeaux Pellegrin, Bordeaux, France.
Pierre PhilouzeENT Department, CHU Croix Rousse, Lyon, France.
Philippe CeruseENT Department, CHU Croix Rousse, Lyon, France.
Marion PerreardENT Department, CHU Caen, Caen, France.
Nicolas SigaudMaxillofacial Surgery, CHU Lyon Sud, Pierre-Bénite, France.
Béatrix BarryENT Department, CHU Bichat, Paris, France.
Pierre RansyENT Department, CHU Lieges, Liège, Belgium.
Philippe SchultzENT Department, CHU Strasbourg, Strasbourg, France.
Olivier MalardENT Department, CHU Nantes, Nantes, France.
Sylvain MorinièreENT Department, CHU Tours, Tours, France.
Anne ChatellierMaxillofacial Surgery, CHU Caen, Caen, France.
Erwan De MonèsENT Department, CHU Bordeaux, Bordeaux, France.
Mireille FoliaENT Department, CHU Dijon, Dijon, France.
François VirardINSERM U1052-CNRS UMR5286, Cancer Research Center, centre Léon Berard, Lyon 1 University, Lyon, France.
Béatrice FerversINSERM UA8, Radiation: Défense, Santé , Environnement, Lyon, France.
GETTEC
Centre Hospitalier Universitaire de Caen Normandie · FRHôpital de la Croix-Rousse · FRInserm · FRCentre Hospitalier Universitaire de Tours · FRCHU Dijon Bourgogne · FRHôpital Lyon Sud · FRHôpital Pellegrin · FRInstitut Gustave Roussy · FRUniversité Claude Bernard Lyon 1 · FRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncidence of oral tongue squamous cell carcinoma (OTSCC) is increasing, especially in young adults, despite decreasing tobacco and alcohol consumption.

methodsThis multicentric retrospective study of 185 young adults with OTSCC (median follow-up 43 months), investigated risk factors, tumour characteristics and oncological outcomes according to the smoking status.

resultsOverall, 38% of patients were smokers (S). Non-smokers (NS) were significantly younger than S. Sex ratios were 1.1 for N and 1.8 for S. NS patients were less frequently cannabis or alcohol users than S, but were more likely to have a history of leukoplakia. Second primaries were observed in NS (4.4%) and in S (12.7%). Despite more frequent local relapse in NS (p = 0.018), there was no difference in diagnostic stage and overall survival between groups.

conclusionOTSCC affects differently young S and NS patients suggesting the existence of a specific clinical entity of OTSCC in non-smoking young adults.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsTongue NeoplasmsHumansNeoplasm Recurrence, LocalRetrospective StudiesSquamous Cell Carcinoma of Head and NeckNon-smokerOral tongueRisk factorsSquamous cell carcinomaYoung patients

Identifiers

PMID33877432
OpenAlexW3154274339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.